HEC
CVRS

Hudson Executive Capital’s CORINDUS VASCULAR ROBOTICS, INC CVRS Stock Holding History

Hudson Executive Capital’s Portfolio CVRS Stock Details CVRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-14,235,545
Closed -$60.9M – 12
2019
Q3 		$60.9M Hold
14,235,545
– – 4.61% 6
2019
Q2 		$42.4M Hold
14,235,545
– – 4.09% 6
2019
Q1 		$24.8M Buy
14,235,545
+2,899,391
+26% +$4.01M 2.3% 7
2018
Q4 		$9.52M Hold
11,336,154
– – 0.96% 7
2018
Q3 		$16.1M Hold
11,336,154
– – 1.3% 7
2018
Q2 		$9.36M Hold
11,336,154
– – 2.08% 7
2018
Q1 		$15.5M Hold
11,336,154
– – 4.58% 6
2017
Q4 		$11.4M Hold
11,336,154
– – 5.5% 6
2017
Q3 		$17.2M Hold
11,336,154
– – 8.67% 5
2017
Q2 		$21.1M Hold
11,336,154
– – 9.69% 4
2017
Q1 		$14.8M Buy
+11,336,154
New +$9.23M 4.07% 8

Hudson Executive Capital's CVRS Position: Q4 2019 in Review

Hudson Executive Capital sold out of CORINDUS VASCULAR ROBOTICS, INC (CVRS) in Q4 2019, closing a stake of 14,235,545 shares — an estimated $60.9M sold.

Hudson Executive Capital first reported a position in CVRS in Q1 2017 and held it in 11 quarters. The position peaked at $60.9M in Q3 2019. 0 funds tracked by Wall St. Rank hold CVRS as of Q4 2019.

  • Hudson Executive Capital reported no remaining CORINDUS VASCULAR ROBOTICS, INC position as of Q4 2019 after selling out during the quarter.
  • Hudson Executive Capital sold 14,235,545 CORINDUS VASCULAR ROBOTICS, INC shares in Q4 2019, an estimated $60.9M.
  • Hudson Executive Capital first reported a position in CORINDUS VASCULAR ROBOTICS, INC in Q1 2017 and held it in 11 quarters.
  • Hudson Executive Capital's CORINDUS VASCULAR ROBOTICS, INC position peaked at $60.9M in Q3 2019.
  • 0 funds tracked by Wall St. Rank held CORINDUS VASCULAR ROBOTICS, INC as of Q4 2019.

Based on Hudson Executive Capital's 13F filing for Q4 2019, filed 14 Feb 2020.